These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24330843)
1. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843 [TBL] [Abstract][Full Text] [Related]
2. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo. Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221 [TBL] [Abstract][Full Text] [Related]
3. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206 [TBL] [Abstract][Full Text] [Related]
4. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692 [TBL] [Abstract][Full Text] [Related]
5. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563 [TBL] [Abstract][Full Text] [Related]
6. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy. Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710 [TBL] [Abstract][Full Text] [Related]
9. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739 [TBL] [Abstract][Full Text] [Related]
10. PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer. Pryczynicz A; Guzińska-Ustymowicz K; Niewiarowska K; Cepowicz D; Kemona A Tumour Biol; 2014 Jul; 35(7):6587-92. PubMed ID: 24696260 [TBL] [Abstract][Full Text] [Related]
11. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis. Hu L; Luo H; Wang W; Li H; He T PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324 [TBL] [Abstract][Full Text] [Related]
13. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. Zhang C; Tian W; Meng L; Qu L; Shou C J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949 [TBL] [Abstract][Full Text] [Related]
14. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Miskad UA; Semba S; Kato H; Yokozaki H Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806 [TBL] [Abstract][Full Text] [Related]
15. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo. Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731 [TBL] [Abstract][Full Text] [Related]
16. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. Dai N; Lu AP; Shou CC; Li JY World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925 [TBL] [Abstract][Full Text] [Related]
17. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value]. Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057 [TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3. Li Z; Zhang G; Li D; Jie Z; Chen H; Xiong J; Liu Y; Cao Y; Jiang M; Le Z; Tan S Biochem Biophys Res Commun; 2015 Jan; 456(1):344-50. PubMed ID: 25475733 [TBL] [Abstract][Full Text] [Related]
19. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Li Z; Cao Y; Jie Z; Liu Y; Li Y; Li J; Zhu G; Liu Z; Tu Y; Peng G; Lee DW; Park SS Cancer Lett; 2012 Oct; 323(1):41-47. PubMed ID: 22469786 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Zhou J; Wang S; Lu J; Li J; Ding Y Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]